IVVD insider files Form 144 to sell 66,000 shares after RSU vesting
Rhea-AI Filing Summary
Form 144 notice for Invivyd, Inc. (IVVD): An insider filed a proposed sale of 66,000 shares of Common Stock on Nasdaq with an aggregate market value of $46,668.60, approximately 0.055% of the reported 120,142,811 shares outstanding. The securities were acquired on 08/15/2025 when 165,000 shares vested as restricted stock units under the company's 2021 Equity Incentive Plan, and the sale was slated for 08/18/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services. The filer certifies absence of undisclosed material adverse information and notes no securities sold in the past three months.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small, routine insider sale following RSU vesting; unlikely to be materially market-moving.
The filing reports a planned sale of 66,000 shares acquired via RSU vesting three days earlier. The sale size represents roughly 0.055% of outstanding shares, indicating the transaction is administrative/liquidity-driven rather than a signal of company distress. Broker details and transaction dates are provided, and the filer attests no undisclosed material adverse information. Given the short window between vesting and notice, investors may note insider liquidity but should treat this as routine equity compensation monetization.
TL;DR: Disclosure aligns with Rule 144 requirements; documentation shows RSU vesting and planned brokered sale.
The notice documents acquisition via restricted stock unit vesting under the 2021 Equity Incentive Plan and identifies the executing broker. The filer affirms the absence of material nonpublic information, and there are no reported sales in the prior three months. From a governance perspective, the filing meets procedural norms for insider dispositions under Rule 144 and references potential Rule 10b5-1 considerations, though no plan adoption date is shown.